Jan. 14 at 3:45 PM
$BLGO fyi
The company raised money for Clyra at a
$95 million valuation.
And for Batteries at a
$44 million valuation.
BioLargo owns 95% of the battery and maybe 46% of the medical.
So Biolargo’s part of those two subsidiaries Combined: ≈
$85.5M
And that is without ONM, AEC and the engineering subsidiary. Those are certainly worth dozens of millions. (Or
$100 million as suggested in the chart above)
So at
$60 million valuation this is in fact undervalued.
And this POOPH caused dip marks a buying opportunity.